This tender is from the country of Brazil in Americas region. The tender was published by Hospital das Clínicas, Federal University of Uberlândia on 07 May 2025 for Oncological Medicines and the like Part II. The last date to submit your bid for this tender was 22 May 2025. This tender is for the companies specializing in Antineoplastic agents, Other therapeutic products, Oncology and similar sectors.
*The deadline for this tender has passed.
Tender Organisation:
Hospital das Clínicas, Federal University of Uberlândia
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33652100 : Antineoplastic agents
33693000 : Other therapeutic products
33100003 : Oncology
Tender Document Type:
Tender Notice
Tender Description:
Oncological Medicines and the like Part II
Tender Bidding Type:
Tender Notice No:
Tender Document:
Looking for more tenders like this one in Antineoplastic agents, Other therapeutic products, Oncology? With over 70 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Healthcare & Medical sector in Brazil, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Brazil is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33652100, 33693000, 33100003, enabling precise filtering. Search by:
While you're viewing a tender in Brazil, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Start your free trial to unlock tenders customized to your Healthcare & Medical, Brazil, and Antineoplastic agents, Other therapeutic products, Oncology categories.